Congratulations to Anthony Vocat winner of the Short Oral Award 2025! His outstanding presentation, “Novel Mycobacteriophages as a Promising Adjunct in the Fight against Drug-Resistant TB and NTM Infections” captivated the scientific committee with its scientific rigor and real-world impact. His work highlights the innovative potential of bacteriophage therapy in addressing one of the most pressing global health challenges: drug-resistant tuberculosis and non-tuberculous mycobacterial infections.
Bravo Dr. Vocat for this well-deserved recognition and for pushing the boundaries of infectious disease research!
Share with:
